Skip to content
Reported HHS stopgap could open a path to unapproved peptides episode artwork

Oct 9, 2026 3 min

Reported HHS stopgap could open a path to unapproved peptides

from The Peps Report

A reported HHS stopgap could open a path for compounding pharmacies to dispense some peptides that aren't FDA-approved, while formal rules are written. Brock walks through what's confirmed (the July advisory vote), what's only reported, how thin the human evidence is for the peptides involved, and why the FDA is still cracking down on "research use only" sellers. Read the full post: Reported HHS stopgap could open a path to unapproved peptides In this episode 00:00 Cold open 00:16 The reported HHS stopgap 00:43 What the FDA panel actually voted 01:14 KPV, MOTS-c, Semax and epithalon: the evidence 02:09 Safety and the FDA's warning letters 02:53 Quick hit: Lilly and retatrutide 03:08 What this means for you Peptides covered KPV MOTS-c Semax Epithalon Retatrutide KPV: A three-amino-acid anti-inflammatory fragment of α-MSH. Sources HHS plans stopgap to allow sales of some unapproved peptides: Washington Post — Becker's Hospital Review, Oct. 8, 2026. https://www.beckershospitalreview.com/glp-1s/hhs-plans-stopgap-to-allow-sales-of-some-unapproved-peptides-washington-post/ FDA balances peptide policy with enforcement against unlawful peptide sellers — Sheppard Mullin, Sept. 18, 2026. https://www.sheppard.com/insights/blogs/fda-balances-peptide-policy-with-enforcement-against-unlawful-peptide-sellers ECRI, ISMP warn of safety risks tied to peptides — Becker's Hospital Review, May 6, 2026. https://www.beckershospitalreview.com/pharmacy/ecri-ismp-warn-of-safety-risks-tied-to-peptides/ NuScience Peptides LLC warning letter 733652 — FDA, Aug. 24, 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nuscience-peptides-llc-733652-08242026 RUO-ined: five peptide vendors learn that research use only is not a legal strategy — ArentFox Schiff, Sept. 18, 2026. https://www.afslaw.com/perspectives/alerts/ruo-ined-five-peptide-vendors-learn-research-use-only-not-legal-strategy 5 things to know if retatrutide is classified as a biologic — AJMC, Oct. 7, 2026. https://www.ajmc.com/view/5-things-to-know-if-retatrutide-is-classified-as-a-biologic Where we buy Amino Club publishes an independent lab report (COA) for every lot; see them on our lab reports page. This is an affiliate link, so we may earn a commission. Educational information, not medical advice. Nicholas and Brock are AI-generated voices; every episode is reviewed by our editor, Ryan E., MS. Read the full article on MyPeps Episode page: https://www.mypeps.info/podcast/reported-hhs-stopgap-could-open-a-path-to-unapproved-peptides

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Reported HHS stopgap could open a path to unapproved peptides

0:00 3:41

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Peps Report?

This episode is 3 minutes long.

When was this The Peps Report episode published?

This episode was published on October 9, 2026.

Can I download this The Peps Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.